Brickell Net Income from 2010 to 2024

BBI Stock  USD 0.90  0.02  2.27%   
Brickell Biotech's Net Loss is decreasing with slightly volatile movements from year to year. Net Loss is estimated to finish at about -33.8 M this year. For the period between 2010 and 2024, Brickell Biotech, Net Loss quarterly trend regression had median of (20,913,000) and r-value of (0.73). View All Fundamentals
 
Net Loss  
First Reported
1990-03-31
Previous Quarter
-9.4 M
Current Value
-1.1 M
Quarterly Volatility
3.8 M
 
Oil Shock
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Brickell Biotech financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Brickell main balance sheet or income statement drivers, such as Depreciation And Amortization of 24 K, Interest Expense of 75.4 K or Selling General Administrative of 10.6 M, as well as many exotic indicators such as Price To Sales Ratio of 0.96, Dividend Yield of 0.0 or Price Book Value Ratio of 0.0198. Brickell financial statements analysis is a perfect complement when working with Brickell Biotech Valuation or Volatility modules.
  
This module can also supplement various Brickell Biotech Technical models . Check out the analysis of Brickell Biotech Correlation against competitors.
For more detail on how to invest in Brickell Stock please use our How to Invest in Brickell Biotech guide.

Latest Brickell Biotech's Net Income Growth Pattern

Below is the plot of the Net Income of Brickell Biotech over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Brickell Biotech financial statement analysis. It represents the amount of money remaining after all of Brickell Biotech operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Brickell Biotech's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Brickell Biotech's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported (39.47 M)10 Years Trend
Slightly volatile
   Net Income   
       Timeline  

Brickell Net Income Regression Statistics

Arithmetic Mean(21,354,064)
Coefficient Of Variation(57.77)
Mean Deviation10,269,269
Median(20,913,000)
Standard Deviation12,336,207
Sample Variance152.2T
Range37.8M
R-Value(0.73)
Mean Square Error77.5T
R-Squared0.53
Significance0
Slope(2,003,075)
Total Sum of Squares2130.5T

Brickell Net Income History

2024-33.8 M
2023-35.6 M
2021-39.5 M
2020-20.9 M
2019-23.9 M
2018-16.3 M
2017-13 M

Other Fundumenentals of Brickell Biotech

About Brickell Biotech Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Brickell Biotech income statement, its balance sheet, and the statement of cash flows. Brickell Biotech investors use historical funamental indicators, such as Brickell Biotech's Net Income, to determine how well the company is positioned to perform in the future. Although Brickell Biotech investors may use each financial statement separately, they are all related. The changes in Brickell Biotech's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Brickell Biotech's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Brickell Biotech Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Brickell Biotech. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2024
Net Loss-35.5 M-33.8 M
Net Loss-35.5 M-33.8 M
Net Loss-35.5 M-33.8 M
Net Income Per E B T 1.15  0.89 
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Brickell Biotech in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Brickell Biotech's short interest history, or implied volatility extrapolated from Brickell Biotech options trading.

Pair Trading with Brickell Biotech

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Brickell Biotech position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Brickell Biotech will appreciate offsetting losses from the drop in the long position's value.

Moving against Brickell Stock

  0.69DNLI Denali Therapeutics Financial Report 13th of May 2024 PairCorr
  0.51MESO Mesoblast TrendingPairCorr
  0.47ONCT Oncternal Therapeutics Financial Report 2nd of May 2024 PairCorr
  0.43MDXG MiMedx Group Sell-off TrendPairCorr
  0.43CVS CVS Health Corp Financial Report 1st of May 2024 PairCorr
The ability to find closely correlated positions to Brickell Biotech could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Brickell Biotech when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Brickell Biotech - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Brickell Biotech to buy it.
The correlation of Brickell Biotech is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Brickell Biotech moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Brickell Biotech moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Brickell Biotech can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Brickell Biotech offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Brickell Biotech's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Brickell Biotech Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Brickell Biotech Stock:
Check out the analysis of Brickell Biotech Correlation against competitors.
For more detail on how to invest in Brickell Stock please use our How to Invest in Brickell Biotech guide.
Note that the Brickell Biotech information on this page should be used as a complementary analysis to other Brickell Biotech's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Complementary Tools for Brickell Stock analysis

When running Brickell Biotech's price analysis, check to measure Brickell Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Brickell Biotech is operating at the current time. Most of Brickell Biotech's value examination focuses on studying past and present price action to predict the probability of Brickell Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Brickell Biotech's price. Additionally, you may evaluate how the addition of Brickell Biotech to your portfolios can decrease your overall portfolio volatility.
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Is Brickell Biotech's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Brickell Biotech. If investors know Brickell will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Brickell Biotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.42)
Revenue Per Share
1.94
Quarterly Revenue Growth
27.576
Return On Assets
(0.80)
Return On Equity
(1.57)
The market value of Brickell Biotech is measured differently than its book value, which is the value of Brickell that is recorded on the company's balance sheet. Investors also form their own opinion of Brickell Biotech's value that differs from its market value or its book value, called intrinsic value, which is Brickell Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Brickell Biotech's market value can be influenced by many factors that don't directly affect Brickell Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Brickell Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Brickell Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Brickell Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.